The NCDC challenged a Lancet study on high MDRO colonisation in Indian ERCP patients, stating colonisation infection and India’s drug-resistant infection rates are still relatively low
The NCDC challenged a Lancet study on high MDRO colonisation in Indian ERCP patients, stating colonisation infection and India’s drug-resistant infection rates are still relatively low by Soban News (international And National News)